Forensic Science International 2009-09-10

Doxepin and nordoxepin concentrations in body fluids and tissues in doxepin associated deaths.

Antonia Gronewold, Andrea Dettling, Hans T Haffner, Gisela Skopp

Index: Forensic Sci. Int. 190(1-3) , 74-9, (2009)

Full Text: HTML

Abstract

Body fluids and tissues in eight doxepin (Dox)-related deaths were investigated in order to prove whether the individual concentration of Dox, the concentration sum of parent drug and its active metabolite N-desmethyldoxepin (NDox) or the concentration ratio Dox/Ndox valuably contribute to making a cause of death determination. Individual case histories were shortly described. Dox and NDox concentrations were determined by LC-MS/MS. Dox concentration measured from two cases was well within a concentration range considered therapeutic, whereas subtherapeutic dosing may have occurred in another two cases. There were two cases of fatal Dox ingestion, as well as a case of high dosage and advanced putrefaction, respectively. The liver concentration sum may be more useful if a fatal ingestion cannot be clearly separated from a person's medication usage. High concentrations could be observed in lung tissue, and combined concentrations of Dox and NDox may also be helpful in making a cause of death determination. There was a trend to a higher concentration sum in the brain with increasing combined levels in blood. Overall, the sum of the absolute figures allows a more accurate interpretation in Dox-related deaths as compared to the molar concentration ratio which may be helpful in acute ingestion. Determination of the N-desmethyl metabolite along with its parent is recommended and analysis should include more than a single specimen.


Related Compounds

Related Articles:

Determination of perhexiline and its metabolite hydroxyperhexiline in human plasma by liquid chromatography/tandem mass spectrometry.

2009-10-01

[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 877(27) , 3025-30, (2009)]

Simultaneous determination of doxepin and nordoxepin in serum using high-performance liquid chromatography.

[J. Chromatogr. A. 419 , 445-51, (1987)]

Quantitative determination of E- and Z-doxepin and E- and Z-desmethyldoxepin by high-performance liquid chromatography.

1995-08-01

[Ther. Drug Monit. 17(4) , 371-6, (1995)]

Bioequivalence: issues and options.

1997-12-01

[J. Pharmacokinet. Biopharm. 25(6) , 743-52, (1997)]

Detection of doxepin and its major metabolite desmethyldoxepin in hair following drug therapy.

1998-10-01

[J. Anal. Toxicol. 22(6) , 531-6, (1998)]

More Articles...